Species Affected
The African horse sickness virus can infect horses, donkeys, mules, zebras, camels and dogs. The most serious infections occur in horses and mules, which appear to be accidental hosts. Zebras and donkeys rarely develop serious clinical signs. Zebras, which are often asymptomatic, are thought to be the natural reservoir hosts in most regions of Africa. Infections in camels have been reported, but appear to be uncommon and asymptomatic. African elephants were found to be seropositive, but these antibodies are now thought to have been the result of a nonspecific reaction in the complement fixation assay. In addition, antibodies were found in sheep, goats and buffaloes in an Egyptian survey.
Geographic Distribution
African horse sickness is endemic in sub-Saharan central and east Africa. This disease sometimes spreads to southern Africa and occasionally to northern Africa. AHS epizootics became less common in southern Africa during the latter half of the 20 th century, possibly due to decreases in free-ranging zebra populations. Outbreaks have been reported outside Africa in Egypt and other parts of the Middle East, as well as in Spain, Portugal, Morocco, Pakistan and India.
Transmission
African horse sickness is transmitted by midges in the genus Culicoides, and is not contagious by casual contact. Both Culicoides imicola and C. bolitinos are known to transmit AHSV in the field; C. imicola appears to be the principal vector. Other species of Culicoides may also be able to spread this virus. The North American species C. variipennis is an efficient vector in the laboratory. Wind has been implicated in the dispersal of infected Culicoides vectors during some epidemics. Transmission by insects other than midges is thought to be a minor source of infection; however, mosquitoes have been implicated as biological vectors, and biting flies in the genera Stomoxys and Tabanus may be able to transmit the virus mechanically. Dogs can be infected experimentally, or if they eat contaminated horsemeat.
Epidemics of African horse sickness tend to occur at cyclic intervals, and are associated with drought followed by heavy rain. Although zebras are thought to be the natural reservoir hosts, horses, mules and donkeys can also develop viremia sufficient to infect Culicoides. Most sources suggest that dogs do not play a significant role in the maintenance or spread of AHSV.
Incubation Period
In experimental infections, the incubation period can range from 2 to 21days. In natural infections, the incubation period appears to be approximately 3 to 5 days for the pulmonary form, 7 to 14 days for the cardiac form, 5 to 7 days for the mixed form and 5 to 14 days for horsesickness fever.
Clinical Signs
Four different forms of African horse sickness exist: the peracute (pulmonary) form, the subacute edematous (cardiac) form, the acute (mixed) form, and horsesickness fever. Symptomatic infections occur most often in horses and mules. The pulmonary and mixed forms usually predominate in susceptible populations of horses. The pulmonary form is also the most common form in dogs. The mildest form, horsesickness fever, tends to be seen in horses with partial immunity, mules and donkeys. This form can also occur in zebras, although most cases in this species are asymptomatic.
The peracute or pulmonary form
The pulmonary form of African horse sickness usually begins with an acute fever, followed by the sudden onset of severe respiratory distress. Infected animals often stand with forelegs spread, head extended, and nostrils fully dilated. Other clinical signs may include tachypnea, forced expiration, profuse sweating, spasmodic coughing, and a frothy serofibrinous nasal exudate. Dyspnea usually progresses rapidly, and the animal often dies within a few hours after the respiratory signs appear.
The subacute edematous or cardiac form
The cardiac form of African horse sickness usually begins with a fever that lasts for 3 to 6 days. Shortly before the fever starts to subside, edematous swellings appear in the supraorbital fossae and eyelids. These swellings later spread to involve the cheeks, lips, tongue, intermandibular space, laryngeal region, and sometimes the neck, shoulders and chest. It is important to note that no edema of the lower legs is observed. Other clinical signs, usually seen in the terminal stages of the disease, can include severe depression, colic, ecchymoses on the ventral surface of the tongue, and petechiae in the conjunctivae. Death often occurs from cardiac failure. If the animal recovers, the swellings gradually subside over the next 3 to 8 days.
The acute or mixed form
In the mixed form of African horse sickness, symptoms of both the pulmonary and cardiac forms are seen. In most cases, the cardiac form is subclinical and is followed by severe respiratory distress. Occasionally, mild respiratory signs may be followed by edema and death from cardiac failure. The mixed form of African horse sickness is rarely diagnosed clinically, but is often seen at necropsy in horses and mules.
Horsesickness fever
In horsesickness fever, the clinical signs are mild. The characteristic fever usually lasts for 3 to 8 days; morning remissions and afternoon exacerbations are often seen. Other symptoms are generally mild and may include mild anorexia or depression, edema of the supraorbital fossae, congested mucous membranes and an increased heart rate. Animals almost always recover from horsesickness fever.
Post Mortem Lesions Click to view images
In the pulmonary form of African horse sickness, interlobular edema of the lungs and hydrothorax are the characteristic lesions. In the most acute cases, frothy fluid flows from the nostrils and the cut surface of the lungs, which are mottled red, noncollapsed and heavy. In more prolonged cases, there may be extensive interstitial and subpleural edema, and hyperemia may be less apparent. Fluid accumulation can occur in the abdominal and thoracic cavities. Occasionally, extensive fluid accumulation may be noted in the thoracic cavity (hydrothorax), with near normal appearance of the lungs. The lymph nodes, particularly the nodes in the thoracic and abdominal cavities, are usually enlarged and edematous. Less often, there may be subcapsular hemorrhages in the spleen, congestion in the renal cortex or gastric fundus, and edematous infiltration around the aorta and trachea. The stomach mucosa may be hyperemic and edematous. Hyperemia and petechial hemorrhages may also be apparent in the small and large intestines, and the pericardium may contain petechiae.
In the cardiac form, a yellow gelatinous infiltrate can be seen in the subcutaneous and intermuscular fascia of the head, neck and shoulders, and occasionally the brisket, ventral abdomen and rump. Hydropericardium is common. The epicardium and endocardium often contain petechial and ecchymotic hemorrhages. Lesions may also be found in the gastrointestinal tract, resembling the pulmonary form. In addition, prominent submucosal edema may be noted in the cecum, large colon and rectum. Ascites can also be seen. In the cardiac form, the lungs are usually normal or slightly engorged, and the thoracic cavity rarely contains excess fluid.
In the mixed form, the post-mortem lesions are a mixture of typical findings from both the cardiac and pulmonary forms.
Morbidity and Mortality
Morbidity and mortality vary with the species of animal, previous immunity and the form of the disease. The pulmonary form of African horse sickness is nearly always fatal, and the mortality rate in the cardiac form is usually 50% or higher. In the mixed form, mortality rate estimates vary from approximately 70% to greater than 80%. In contrast, horsesickness fever very rarely results in death.
Horses are particularly susceptible to the more severe forms of African horse sickness. The mixed and pulmonary forms tend to predominate in susceptible horse populations, and the mortality rate is usually 50% to 95%. In other species of Equidae, African horse sickness is generally less severe. In mules, the mortality rate is approxi-mately 50%, and in European and Asian donkeys, 5% to 10%. Death is rare in African donkeys and zebra.
Animals that recover from African horse sickness develop good immunity to the infecting serotype and partial immunity to other serotypes.
Diagnosis

Clinical
African horse sickness should be suspected in animals with typical symptoms of the cardiac, pulmonary or mixed forms of the disease. The supraorbital swellings are particularly characteristic of this disease. The horsesickness form can be difficult to diagnose.
Differential diagnosis
The differential diagnosis includes equine viral arteritis, equine infectious anemia, Hendra virus infection, purpura hemorrhagica and equine piroplasmosis. In Africa, equine encephalosis virus, another orbivirus transmitted by Culicoides, causes a syndrome resembling horsesickness fever. Toxins, anthrax and other causes of sudden death, as well as diseases that result in severe respiratory distress, should also be considered.
Laboratory tests
African horse sickness can be diagnosed by isolating the virus or detecting its nucleic acids or antigens. More than one test should be used to diagnose an outbreak (particularly the index case) whenever possible.
Virus isolation is particularly important when outbreaks are seen outside endemic areas. AHSV can be isolated in embryonated eggs, by intracerebral inoculation of newborn mice, or in cell cultures. Suitable cultures for inoculation include baby hamster kidney (BHK-21), monkey stable (MS) and African green monkey kidney (Vero) cells. Virus isolation in mice is the preferred technique for primary isolation. The isolated virus can be identified by complement fixation or immunofluorescence. The isolate should be serotyped using virus neutralization or other methods.
AHSV antigens can be detected with enzyme-linked immunosorbent assays (ELISAs). A reverse-transcription polymerase chain reaction (RT-PCR) technique is used to detect viral RNA. A recently developed type-specific RT-PCR assay can be used for rapid serotyping.
Serology can also be used to diagnose African horse sickness. Antibodies can be detected within 8 to 14 days after infection, and may persist for one to four years. Available serologic tests include complement fixation, ELISAs, immunoblotting and virus neutralization. The indirect ELISA and complement fixation tests are the prescribed tests for international trade. The virus neutralization test is used for serotyping. Immunodiffusion and hemagglutination inhibition tests have also been described. AHSV does not cross-react with other known orbiviruses.
Samples to collect
Before collecting or sending any samples from animals with a suspected foreign animal disease, the proper authorities should be contacted. Samples should only be sent under secure conditions and to authorized laboratories to prevent the spread of the disease.
In live animals, blood samples collected into anticoagulant should be taken for virus isolation. Success is most likely if these samples are collected early during the febrile stage. Necropsy samples for virus isolation should include samples of the spleen, lung and lymph nodes. The samples for virus isolation should be stored and transported at 4°C (39°F). Serum should also be taken for serology. Paired serum samples are recommended, and are particularly important in areas where the disease is endemic.
Recommended actions if African horse sickness is suspected
Notification of authorities
African horse sickness should be reported immediately to state or federal authorities upon diagnosis or suspicion of the disease.
Federal 
Control
Horses cannot enter the US from an African horse sickness endemic country unless they have been in an AHS-free country or area of the world for at least 60 days. Upon entering the US, horses are then subject to the regular 3 or 7 day quarantine period at the point of entry.
If African horse sickness is detected in a country where it is not endemic, a strict quarantine zone and movement controls should be established. Euthanasia of infected and exposed animals may be considered. Whenever possible, all Equidae should be stabled in insectproof housing. At a minimum, stabling from dusk to dawn, the period when Culicoides are most active, is recommended. Vector control measures such as modifications of Culicoides breeding areas, insect repellents, and targeted applications of insecticides or larvicides may also be useful.
Monitoring for fever may be helpful for the early detection of African horse sickness. Each susceptible animal should have its temperature taken regularly (optimally, twice daily). Those animals that develop a fever should be kept in insect-free stables until the cause of the fever has been established, or killed to prevent potential virus transmission to the vector.
Vaccination may be considered once the diagnosis has been confirmed. Attenuated vaccines are routinely used for control in endemic regions, but may not be licensed in other areas. These vaccines result in viremia, and the viruses could theoretically reassort with an out-break virus. Attenuated vaccines may not be safe in AHSfree countries. They are also teratogenic. A killed vaccine has been produced against serotype 4 but is no longer available; no killed or subunit vaccines are currently manufactured commercially.
African horse sickness is not a contagious disease; however, the virus can be inactivated in the laboratory with formalin, β -propriolactone, acetylethyleneimine derivatives or radiation. It is also destroyed at a pH less than 6, or pH 12 or greater. Acidic disinfectants such as 2% acetic or citric acid have been recommended for decontamination when it is warranted.
AHSV can survive in frozen meat, but is inactivated at temperatures greater than 60ºC (140ºF). Due to pH fluctuations, this virus is also rapidly destroyed in carcasses that have undergone rigor mortis.
Public Health
Humans are not natural hosts for the African horse sickness virus, and no cases have been seen after contact with field strains. However, a neurotropic vaccine strain, adapted to mice, can cause encephalitis and retinitis in humans. 
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